COL1A1 and cancer: Despite the difference in the origins of primary cancers, anatomic locations, and treatment histories, our recent work suggests that pan-brain metastasis biomarkers such as COL1A1/COL1A210 and CD37/cystatin A/IL-23A11 are strongly associated with responses to radiotherapies, overall survival, and distant brain failure.